Ingen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with patented proprietary technology for the growing $4 Billion Respiratory-Market, is pleased to announce the launch of their new website. With a dynamic B2B (Business-to-Business)-eCommerce platform, Ingen will create branding and revenue channels with millions of homecare patients, medical supplies distributors, hospitals, physicians, government purchasing programs and OEM medical device manufacturers.
Ingen has designed the new website to provide the B2B-eCommerce structure that allows Ingen the capacity in selling its Oxyview products online directly through a recognized National Distributor in order to create the retail and branding of the products through thousands of distributors.
The new website went "live" earlier this month and is expected to reach millions of home oxygen patients over the next several months. According to a 2002 statistic report from the Prevention's National Center for Health Statistics the total estimated cost of Chronic Obstructive Pulmonary Disease (COPD) was $32.1 Billion. The Ingen products have a potential market for annual sales of $50 Million which represent 10% of the current annual $500M nasal cannula sales.
"Ingen has now launched a global branding and retail market for our Smart Nasal Cannula. Our product is an advanced technology that is price competitive; and supported by COPD Foundations and Respiratory Organizations. Sales are expected to skyrocket. We will release a certified analyst report in 2 weeks that provides a valuation of our company," stated Gary B. Tilden, Chairman.
VISIT OUR WEBSITE AT: www.ingen-tech.com or FACT SHEET AT: http://ingen-tech.com/files/documents/ignt-1112.pdf
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
Ingen Technologies, Inc. Riverside, California Contact: Gary Tilden 951-688-7840